Affordable high performance SERS substrates that don't sacrifice sensitivity and repeatability.

About Our Company

Diagnostic anSERS Inc. is dedicated to producing affordable ink-jet printed SERS substrates.

Surface Enhanced Raman Spectroscopy (SERS) requires two components: a Raman spectrometer and a SERS substrate. However, the sheer cost of the non-reusable SERS substrates, which are frequently manufactured in clean rooms, drastically limits its use.

Through a patent-pending ink-jet printing process, our P-SERS™ SERS substrates are a produced at a fraction of the cost without sacrificing sensitivity.

In addition to being used as a “traditional” SERS substrate (pipetted on sample), the wicking and flexible nature of our SERS sensors enable their use in swab and dipstick formats.

If you have any questions on sales, technical aspects, investment, or anything else, feel free to contact us.

Got Questions? We.Have@DiagnosticanSERS.com

Read More

News

August 6, 2015 |

Diagnostic anSERS featured in The Diamondback

Diagnostic anSERS’ NSF project to develop drugged driving test was featured in this week’s issue of The Diamondback....

July 29, 2015 |

Diagnostic anSERS interviewed live on KCBS

Diagnostic anSERS was interviewed live on KCBS about our upcoming saliva test for identifying drugged drivers! @DA_SERS interviewed live on KCBS to discuss upcoming saliva test for identifying drugged drivers https://t.co/zJ6cfGzPRa — Diagnostic anSERS (@DA_SERS) July 29, 2015 UMD #BioE alum Dr. Eric Hoppmann of @DA_SERS to speak on air ~2:20 ET w/ @KCBSNews about paper-based test for identifying drugged drivers. — UMD Fischell BioE (@UMDBioE) July 28, 2015 (July 28, 2015 @ 2:35...

July 20, 2015 |

Sensing Drugged Driving: Diagnostic anSERS receives SBIR for roadside drug test

July 20th 2015 – for immediate release • Further information: Sean Virgile, (301) 886-0280 x1021 Read the release at PRWeb • PDF Version Sensing Drugged Driving: Diagnostic anSERS receives SBIR for roadside drug test Diagnostic anSERS Inc. has been awarded a $150,000 grant by the National Science Foundation to develop a paper-based test for identifying drugged drivers, building on their low-cost yet highly sensitive and reliable P-SERS™ testing platform. College Park, MD – Diagnostic anSERS announced today that the National Science Foundation (NSF) has awarded the company a Small Business Innovation Research (SBIR) Phase I grant to identify drugged drivers. With the $150,000 funding, Diagnostic anSERS will develop a paper-based test strip to enable rapid...

April 20, 2015 |

P-SERS™ at SPIE:DSS 2015

Stop by our booth at SPIE:DSS in Baltimore Maryland, #862, April 21-23 2015, where we will be showing off P-SERS™ 2.0, as well as exciting advancements in modular spectrometer systems. We are also excited to announce that we will be holding a live demonstration of P-SERS™ in the product demonstration area of the exhibit hall, on April 23 from 11:30 AM until noon. At the demonstration, we will talk about exciting applications which improve security, food safety, process control and efficiency in analytical labs, as well as enable the verification of product authenticity. The demo will include a live demonstration of pesticide residue detection by swabbing a banana as well as a liquor counterfeiting...

March 2, 2015 |

P-SERS™ for Cancer Biomarker Detection featured in American Pharmaceutical Review

P-SERS™ substrates have been featured in an article published in the American Pharmaceutical Review entitled Raman Spectroscopy Could Facilitate Deployment of Amantadine-Based Cancer Screening Technology – Enabling the Transition from Labs to Villages”. Our partners at Innovative Photonic Solutions and BioMark Diagnostics describe how the combination of functionalized P-SERS™ substrates with reader hardware from IPS has the potential to revolutionize BioMark’s early stage cancer screening test. Currently an expensive central lab test which costs hundreds of dollars, P-SERS™ has the potential to enable cancer screening to be performed in clinics in first and third-world countries for a tiny fraction of the cost of a central-lab test. In partnership with BioMark Diagnostics, research efforts are...

Read More